Prothrombin complex concentrates for DOAC-associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Res Pract Thromb Haemost · 2020 · PMC7354417 · PMID 32685875

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = .06so close (0.05 < p ≤ 0.1)

The difference in ETP between DOAC‐treated patients and healthy volunteers did not reach statistical significance ( P = .06 for FXa inhibitors and P = .09 for dabigatran).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.